Investigation of differentially expressed genes in ER plus PR- invasive breast cancer

被引：0
|
作者：
Althobiti, M. M. A. [1 ]
Albugami, R. R. A. [2 ]
Alnamnakani, M. M. A. [2 ]
Alharbi, S. A. A. [1 ]
Lashin, A. G. [3 ]
机构：
[1] Shaqra Univ, Riyadh, Saudi Arabia
[2] King Fahad Med City, Riyadh, Saudi Arabia
[3] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2024年 / 264卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P18
引用
收藏
页码：S11 / S12
页数：2
相关论文
共 50 条
  • [1] Genetic and clinical landscape of ER plus /PR- breast cancer in China
    Dai, Danian
    Wu, Hongmei
    Zhuang, Hongkai
    Chen, Rong
    Long, Cheng
    Chen, Bo
    BMC CANCER, 2023, 23 (01)
  • [2] Are ER plus PR plus and ER plus PR- breast tumors genetically different? A CGH array study
    Carracedo, Alma
    Salido, Marta
    Corominas, Josep M.
    Rojo, Federico
    Ferreira, Bibiana I.
    Suela, Javier
    Tusquets, Ignasi
    Corzo, Cristina
    Segura, Marcel
    Espinet, Blanca
    Cigudosa, Juan C.
    Arumi, Montserrat
    Albanell, Joan
    Serrano, Sergi
    Sole, Francesc
    CANCER GENETICS, 2012, 205 (04) : 138 - 146
  • [3] A comparison of tumor characteristics between ER plus /PR plus and ER plus /PR- breast tumors in Chinese women
    Zhou, L.
    Yin, W.
    Lu, J.
    Shi, D.
    Liu, G.
    Di, G.
    Wu, J.
    Shen, K.
    Lu, H.
    Shen, Z.
    Shao, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Comparison of the sensitivity to endocrine therapy of PR plus /ER- patients and ER plus /PR- patients with HER2+breast cancer
    Hao, X.
    Liu, Y.
    Hui, R.
    Zhang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Genetic and clinical landscape of ER + /PR- breast cancer in China
    Danian Dai
    Hongmei Wu
    Hongkai Zhuang
    Rong Chen
    Cheng Long
    Bo Chen
    BMC Cancer, 23
  • [6] Characterization of Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC)
    Shen, Tiansheng
    Guo, Tao
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 72A - 73A
  • [7] Characterization of Estrogen Receptor Positive/Progesterone Receptor Negative/(ER plus /PR-) Breast Cancer (BC)
    Shen, Tiansheng
    Guo, Tao
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 72A - 73A
  • [8] ER plus /PR- phenotype exhibits more aggressive biological features and worse outcome compared with ER plus /PR plus phenotype in HER2-negative inflammatory breast cancer
    Luo, Yunbo
    Li, Qingyun
    Fang, Jiang
    Pan, Chaoying
    Zhang, Lingxing
    Xu, Xia
    Qian, Shuangqiang
    Zhao, Xiaobo
    Hou, Lingmi
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [9] Identification of differentially expressed genes in breast cancer
    Salceda S.
    Drumright C.
    Diegidio A.
    Liang B.
    Hu P.
    Sun Y.
    Hoang V.V.
    Munteanu A.
    Recipon H.
    Cafferkey R.
    Macina R.A.
    Nature Genetics, 2001, 27 (Suppl 4) : 83 - 84
  • [10] Identification of differentially expressed genes in breast cancer
    Burger, AM
    Li, H
    Panayiotakis, A
    Salesiotis, AN
    Seth, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (02) : 395 - 400
12345